-
Citi Adjusts 2023 N. America Focus List, Adds Vulcan Materials (VMC), Removes 4 Other Biotech Names
-
Ultragenyx to Participate at Investor Conferences in September
-
Citi Reiterates $130 PT on Ultragenyx Pharma (RARE), Opens Catalyst Watch
-
Ultragenyx to Participate at Citi BioPharma Conference
-
Ultragenyx to Participate at Citi BioPharma Conference
-
Ultragenyx to Participate in Panel at Citi’s 16th Annual BioPharma Healthcare Conference
-
Ultragenyx to Participate in Panel at Citi’s 16th Annual BioPharma Healthcare Conference
-
UPDATE: Citi Upgrades Ultragenyx Pharma (RARE) to Buy
-
Ultragenyx to Present at Upcoming Investor Conferences
-
Ultragenyx to Present at Upcoming Investor Conferences
-
Ultragenyx Pharma (RARE) PT Lowered to $66 at Citi
-
Ultragenyx Pharma (RARE) PT Raised to $72 at Citi After Analyst Day
-
Ultragenyx Pharma (RARE) PT Raised to $62 at Citi
-
Ultragenyx Pharma (RARE) PT Rises To $62 At Citi But Remains At Neutral Pending Higher Dose Data
-
Citi Upgrades Ultragenyx Pharma (RARE) to Neutral
-
Ultragenyx Pharma (RARE) PT Lowered to $46 at Citi
-
Omega's 13F Shows Increase in Ocwen (OCN), Synchrony (SYF), United (UAL), Exits Zynga (ZNGA) (More...)
-
Ultragenyx Pharma (RARE) PT Raised to $49 at Citi
-
Ultragenyx Pharma (RARE): More Cracks in the Armor, PT To $43 - Citi
-
Citi Upgrades Dimension Therapeutics (DMTX) to Neutral (Yesterday)
-
Ultragenyx Pharma (RARE) PT Lowered to $45 at Citi
-
Pre-Open Stock Movers 04/19: (ARGS) (CYTR) (IMGN) Higher; (ADPT) (LBY) (IBM) Lower (more...)
-
Pre-Open Movers 03/23: (HTGM) (SSH) (PVH) (FEYE) Higher; (HTBX) (RARE) (BLCM) Lower (more...)
-
Notable Analyst Rating Changes 11/14: (SQ) (PTCT) (CLF) Upgraded; (STI) (STLD) (RARE) Downgraded
-
Citi Downgrades Ultragenyx Pharma (RARE) to Sell
-
Citi Highlights Potential Biotech M&A Names Following Relypsa Deal (ADRX) (OPHT) (PBYI) (PTLA) (RARE) (VSAR)
-
Citi Upgrades Ultragenyx Pharma (RARE) to Neutral
-
Citi Starts Ultragenyx Pharma (RARE) at Sell
-
Pre-Open Stock Movers 07/16: (NFLX) (ANFI) (INTC) Higher; (ANR) (ROVI) (GRMN) Lower (more...)
-
Notable Analyst Rating Changes 3/31: (DHI) (TEVA) (CNDO) Upgraded; (SLB) (DB) (WPT) Downgraded
-
Pre-Open Stock Movers 7/9: (LXRX) (NQ) (AVAV) Higher; (GIMO) (TCS) (SIMG) Lower (more...)

